Give Warts a Close Shave

Primary Viewpoints: Immunizations with Dr Steven P. Furr

The elinzanetant NDA is based on data, including long-term efficacy, from the OASIS phase 3 clinical trial program, according to Bayer.

Keith A. Reynolds

October 1st 2024

Single vs Multiple Inhaler Triple Therapy for COPD Could Triple Adherence, Persistence: International Data

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

CHEST 2024: Combined data from 4 continents found consistently better adherence/persistence when COPD triple therapy was initiated with a single inhaler.

October 25th 2023

Early Identification, Treatment of COPD Reduces Exacerbations, Health Care Burden

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

/ image credit lung tissue COPD: ©SciePro/stock.adobe.com

Decrease in MHT Use over Past 2 Decades: Daily Dose

CHEST 2024. Initial treatment for people with COPD should begin early in the disease and leads to significantly reduced risk for exacerbations and inpatient treatment.

Elinzanetant Update: FDA Accepts Bayer NDA, Sets July 2025 PDUFA Date

Your daily dose of the clinical news you may have missed.

Related Content

Primary Viewpoints: Immunizations with Dr Steven P. Furr

The elinzanetant NDA is based on data, including long-term efficacy, from the OASIS phase 3 clinical trial program, according to Bayer.

Keith A. Reynolds

October 1st 2024

Single vs Multiple Inhaler Triple Therapy for COPD Could Triple Adherence, Persistence: International Data

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

CHEST 2024: Combined data from 4 continents found consistently better adherence/persistence when COPD triple therapy was initiated with a single inhaler.

October 25th 2023

Early Identification, Treatment of COPD Reduces Exacerbations, Health Care Burden

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Decrease in MHT Use over Past 2 Decades: Daily Dose

CHEST 2024. Initial treatment for people with COPD should begin early in the disease and leads to significantly reduced risk for exacerbations and inpatient treatment.